Search research articles
Contact Us
Filters
Showing results (41-50 of 60) with videos related to
Page
of 6
Sort By:
Interactive Cardiovascular and Thoracic Surgery
|
November 22, 2014
Does the introduction of a comprehensive structured training programme for endoscopic vein harvesting improve conduit quality? A multicentre pilot study
Bhuvaneswari Krishnamoorthy, William R Critchley, Peter Bhinda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 25, 2014
Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial
T Gruenberger, J Bridgewater, I Chau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1994
Doxorubicin and cisplatin with granulocyte colony-stimulating factor as adjuvant chemotherapy for osteosarcoma: phase II trial of the European Osteosarcoma Intergroup
D Ornadel, R L Souhami, J Whelan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 13, 2022
Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
A Vogel, J Bridgewater, J Edeline, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 2, 2009
Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study
E Van Cutsem, F Rivera, S Berry, et al.
ESMO Open
|
April 10, 2025
Molecular targeted maintenance therapy versus standard of care in advanced biliary cancer: an international, randomised, controlled, open-label, phase III umbrella trial (SAFIR-ABC10-Precision Medicine)
D Malka, I Borbath, A Lopes, et al.
British Journal of Cancer
|
October 27, 2011
Clinical activity of patupilone in patients with pretreated advanced/metastatic colon cancer: results of a phase I dose escalation trial
B Melichar, E Casado, J Bridgewater, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 21, 2015
Prognostic factors for progression-free and overall survival in advanced biliary tract cancer
J Bridgewater, A Lopes, H Wasan, et al.
Frontiers in Nutrition
|
February 25, 2022
Interpreting Clinical Trials With Omega-3 Supplements in the Context of Ancestry and <i>FADS</i> Genetic Variation
Floyd H Chilton, Ani Manichaikul, Chaojie Yang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 16, 2008
Two different first-line 5-fluorouracil regimens with or without oxaliplatin in patients with metastatic colorectal cancer
D Cunningham, B Sirohi, A Pluzanska, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 60) with videos related to
Sort By:
Page
of 6
Interactive Cardiovascular and Thoracic Surgery
|
November 22, 2014
Does the introduction of a comprehensive structured training programme for endoscopic vein harvesting improve conduit quality? A multicentre pilot study
Bhuvaneswari Krishnamoorthy, William R Critchley, Peter Bhinda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 25, 2014
Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial
T Gruenberger, J Bridgewater, I Chau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1994
Doxorubicin and cisplatin with granulocyte colony-stimulating factor as adjuvant chemotherapy for osteosarcoma: phase II trial of the European Osteosarcoma Intergroup
D Ornadel, R L Souhami, J Whelan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 13, 2022
Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
A Vogel, J Bridgewater, J Edeline, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 2, 2009
Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study
E Van Cutsem, F Rivera, S Berry, et al.
ESMO Open
|
April 10, 2025
Molecular targeted maintenance therapy versus standard of care in advanced biliary cancer: an international, randomised, controlled, open-label, phase III umbrella trial (SAFIR-ABC10-Precision Medicine)
D Malka, I Borbath, A Lopes, et al.
British Journal of Cancer
|
October 27, 2011
Clinical activity of patupilone in patients with pretreated advanced/metastatic colon cancer: results of a phase I dose escalation trial
B Melichar, E Casado, J Bridgewater, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 21, 2015
Prognostic factors for progression-free and overall survival in advanced biliary tract cancer
J Bridgewater, A Lopes, H Wasan, et al.
Frontiers in Nutrition
|
February 25, 2022
Interpreting Clinical Trials With Omega-3 Supplements in the Context of Ancestry and <i>FADS</i> Genetic Variation
Floyd H Chilton, Ani Manichaikul, Chaojie Yang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 16, 2008
Two different first-line 5-fluorouracil regimens with or without oxaliplatin in patients with metastatic colorectal cancer
D Cunningham, B Sirohi, A Pluzanska, et al.
Page
of 6